Elite Pharmaceuticals
Northvale
About Elite Pharmaceuticals
Elite Pharmaceuticals, Inc. specializes in the development of oral controlled release products, such as delayed, sustained, targeted and pulsatile release tablets, pellets, capsules, granules and powders. The Company’s primary focus is in the therapeutic areas of pain management, allergy, cardiovascular and infection.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $50K – $100K
- Total funding: $7.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2020)
- Ticker: otcqb:ELTP
- Website: elitepharma.com
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/elite-pharmaceuticals-2224963 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.